Polar Asset Management Partners’s Alder Biopharmaceuticals ALDR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-175,000
Closed -$3.3M 545
2019
Q3
$3.3M Buy
+175,000
New +$2M 0.06% 244

Polar Asset Management Partners's ALDR Position: Q4 2019 in Review

Polar Asset Management Partners sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 175,000 shares — an estimated $3.3M sold.

Polar Asset Management Partners first reported a position in ALDR in Q3 2019 and held it in 1 quarter. The position peaked at $3.3M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

  • Polar Asset Management Partners reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Polar Asset Management Partners sold 175,000 Alder Biopharmaceuticals shares in Q4 2019, an estimated $3.3M.
  • Polar Asset Management Partners first reported a position in Alder Biopharmaceuticals in Q3 2019 and held it in 1 quarter.
  • Polar Asset Management Partners's Alder Biopharmaceuticals position peaked at $3.3M in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Polar Asset Management Partners's 13F filing for Q4 2019, filed 14 Feb 2020.